QLM3003 / Qilu Pharma - LARVOL DELTA

QLM3003-301: Efficacy and Safety Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis (clinicaltrials.gov) - P3 | N=360 | Recruiting | Sponsor: Qilu Pharmaceutical Co., Ltd. | Not yet recruiting ➔ Recruiting

Enrollment open • Atopic Dermatitis • Dermatitis • Dermatology • Immunology

A Phase 2 Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis (clinicaltrials.gov) - P2 | N=120 | Completed | Sponsor: Qilu Pharmaceutical Co., Ltd. | Not yet recruiting ➔ Completed

Trial completion • Atopic Dermatitis • Dermatitis • Dermatology • Immunology

QLM3003-301: A Phase 3 Study of QLM3003 Ointment (clinicaltrials.gov) - P3 | N=360 | Not yet recruiting | Sponsor: Qilu Pharmaceutical Co., Ltd.

New P3 trial • Atopic Dermatitis • Dermatitis • Dermatology • Immunology

Safety, Tolerability, and Pharmacokinetic Study of QLM3003 in Healthy Adult Subjects (clinicaltrials.gov) - P1 | N=40 | Completed | Sponsor: Qilu Pharmaceutical Co., Ltd. | Active, not recruiting ➔ Completed

Trial completion • Atopic Dermatitis • Dermatitis • Dermatology • Immunology

A Phase 2 Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis (clinicaltrials.gov) - P2 | N=120 | Not yet recruiting | Sponsor: Qilu Pharmaceutical Co., Ltd.

New P2 trial • Atopic Dermatitis • Dermatitis • Dermatology • Immunology

Safety, Tolerability, and Pharmacokinetic Study of QLM3003 in Healthy Adult Subjects (clinicaltrials.gov) - P1 | N=40 | Active, not recruiting | Sponsor: Qilu Pharmaceutical Co., Ltd. | Recruiting ➔ Active, not recruiting

Enrollment closed • Atopic Dermatitis • Dermatitis • Dermatology • Immunology

Safety, Tolerability, and Pharmacokinetic Study of QLM3003 in Healthy Adult Subjects (clinicaltrials.gov) - P1 | N=40 | Recruiting | Sponsor: Qilu Pharmaceutical Co., Ltd.

New P1 trial • Atopic Dermatitis • Dermatitis • Dermatology • Immunology